These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

212 related articles for article (PubMed ID: 19651864)

  • 21. Purification and Characterization of Botulinum Neurotoxin FA from a Genetically Modified Clostridium botulinum Strain.
    Pellett S; Tepp WH; Bradshaw M; Kalb SR; Dykes JK; Lin G; Nawrocki EM; Pier CL; Barr JR; Maslanka SE; Johnson EA
    mSphere; 2016; 1(1):. PubMed ID: 27303710
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Natural Compounds and Their Analogues as Potent Antidotes against the Most Poisonous Bacterial Toxin.
    Patel KB; Cai S; Adler M; Singh BK; Parmar VS; Singh BR
    Appl Environ Microbiol; 2018 Dec; 84(24):. PubMed ID: 30389764
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Production of a neutralizing mouse-human chimeric antibody against botulinum neurotoxin serotype E.
    Mukamoto M; Maeda H; Kohda T; Nozaki C; Takahashi M; Kozaki S
    Jpn J Infect Dis; 2013; 66(1):46-50. PubMed ID: 23429085
    [TBL] [Abstract][Full Text] [Related]  

  • 24. A Three-Monoclonal Antibody Combination Potently Neutralizes BoNT/G Toxin in Mice.
    Fan Y; Lou J; Tam CC; Wen W; Conrad F; Leal da Silva Alves P; Cheng LW; Garcia-Rodriguez C; Farr-Jones S; Marks JD
    Toxins (Basel); 2023 Apr; 15(5):. PubMed ID: 37235351
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Preparation of egg yolk antibodies against BoNT/B and their passive protection in mouse models.
    You Z; Yang H; Xin W; Kang L; Gao S; Wang J; Zhang T; Wang J
    Hum Vaccin Immunother; 2014; 10(8):2321-7. PubMed ID: 25424938
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Induction of protective neutralizing antibody responses against botulinum neurotoxin serotype C using plasmid carried by PLGA nanoparticles.
    Ruwona TB; Xu H; Li J; Diaz-Arévalo D; Kumar A; Zeng M; Cui Z
    Hum Vaccin Immunother; 2016 May; 12(5):1188-92. PubMed ID: 26837242
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Monoclonal Antibody Combinations Prevent Serotype A and Serotype B Inhalational Botulism in a Guinea Pig Model.
    Tomic MT; Espinoza Y; Martinez Z; Pham K; Cobb RR; Snow DM; Earnhart CG; Pals T; Syar ES; Niemuth N; Kobs DJ; Farr-Jones S; Marks JD
    Toxins (Basel); 2019 Apr; 11(4):. PubMed ID: 30959899
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Epitope characterization and variable region sequence of f1-40, a high-affinity monoclonal antibody to botulinum neurotoxin type a (Hall strain).
    Scotcher MC; McGarvey JA; Johnson EA; Stanker LH
    PLoS One; 2009; 4(3):e4924. PubMed ID: 19290051
    [TBL] [Abstract][Full Text] [Related]  

  • 29. The receptor binding domain of botulinum neurotoxin serotype A (BoNT/A) inhibits BoNT/A and BoNT/E intoxications in vivo.
    Ben David A; Diamant E; Barnea A; Rosen O; Torgeman A; Zichel R
    Clin Vaccine Immunol; 2013 Aug; 20(8):1266-73. PubMed ID: 23761665
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Characterization of the monoclonal antibody response to botulinum neurotoxin type A in the complexed and uncomplexed forms.
    Zhao H; Nakamura K; Kohda T; Mukamoto M; Kozaki S
    Jpn J Infect Dis; 2012; 65(2):138-45. PubMed ID: 22446121
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Isolation and characterization of a neutralizing antibody specific to internalization domain of Clostridium botulinum neurotoxin type B.
    Yang GH; Kim KS; Kim HW; Jeong ST; Huh GH; Kim JC; Jung HH
    Toxicon; 2004 Jul; 44(1):19-25. PubMed ID: 15225558
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Subunit vaccine against the seven serotypes of botulism.
    Baldwin MR; Tepp WH; Przedpelski A; Pier CL; Bradshaw M; Johnson EA; Barbieri JT
    Infect Immun; 2008 Mar; 76(3):1314-8. PubMed ID: 18070903
    [TBL] [Abstract][Full Text] [Related]  

  • 33. The Light Chain Defines the Duration of Action of Botulinum Toxin Serotype A Subtypes.
    Pellett S; Bradshaw M; Tepp WH; Pier CL; Whitemarsh RCM; Chen C; Barbieri JT; Johnson EA
    mBio; 2018 Mar; 9(2):. PubMed ID: 29588398
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Botulinum neurotoxins and botulism: a novel therapeutic approach.
    Thanongsaksrikul J; Chaicumpa W
    Toxins (Basel); 2011 May; 3(5):469-88. PubMed ID: 22069720
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Development and evaluation of candidate subunit vaccine and novel antitoxin against botulinum neurotoxin serotype E.
    Shi DY; Liu FJ; Mao YY; Cui RT; Lu JS; Yu YZ; Dong XJ; Yang ZX; Sun ZW; Pang XB
    Hum Vaccin Immunother; 2020; 16(1):100-108. PubMed ID: 31210561
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Development of human-like scFv-Fc antibodies neutralizing Botulinum toxin serotype B.
    Rasetti-Escargueil C; Avril A; Chahboun S; Tierney R; Bak N; Miethe S; Mazuet C; Popoff MR; Thullier P; Hust M; Pelat T; Sesardic D
    MAbs; 2015; 7(6):1161-77. PubMed ID: 26381852
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Two VHH Antibodies Neutralize Botulinum Neurotoxin E1 by Blocking Its Membrane Translocation in Host Cells.
    Lam KH; Perry K; Shoemaker CB; Jin R
    Toxins (Basel); 2020 Sep; 12(10):. PubMed ID: 32992561
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Extraction and inhibition of enzymatic activity of botulinum neurotoxins/A1, /A2, and /A3 by a panel of monoclonal anti-BoNT/A antibodies.
    Kalb SR; Lou J; Garcia-Rodriguez C; Geren IN; Smith TJ; Moura H; Marks JD; Smith LA; Pirkle JL; Barr JR
    PLoS One; 2009; 4(4):e5355. PubMed ID: 19399171
    [TBL] [Abstract][Full Text] [Related]  

  • 39. A new neutralizing antibody against botulinum neurotoxin B recognizes the protein receptor binding sites for synaptotagmins II.
    Wang H; Li T; Shi J; Cai K; Hou X; Wang Q; Xiao L; Tu W; Liu H; Gao X
    Microbes Infect; 2010 Nov; 12(12-13):1012-8. PubMed ID: 20650331
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Monoclonal Antibodies Targeting the Alpha-Exosite of Botulinum Neurotoxin Serotype/A Inhibit Catalytic Activity.
    Fan Y; Geren IN; Dong J; Lou J; Wen W; Conrad F; Smith TJ; Smith LA; Ho M; Pires-Alves M; Wilson BA; Marks JD
    PLoS One; 2015; 10(8):e0135306. PubMed ID: 26275214
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.